
|Articles|March 1, 2003
Division will focus on ophthalmic clinical trials
Princeton, NJ-Advanced Biomedical Research Inc. has launched a new ophthalmic division, called ABR InVision, devoted to conducting clinical studies in glaucoma, retinal and corneal diseases, cataract, refractive surgery, and neuroprotection.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1
2
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
3
Collarettes common but largely stable in moderate-to-severe dry eye patients
4
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada
5

















































.png)


